ASCO Data Show A Battle Ahead For Roche And Genmab’s Lymphoma Bispecifics

Roche Leads But Rivals Could Have Efficacy Edge

 
• By Andrew McConaghie
  
ASCO 2019
The ASCO meeting returns to an in-person format in Chicago for the first time since 2019. • Source: ASCO

More from Business

More from Scrip